Illness Anxiety Disorder

Clinical picture

• Preoccupation centers on the meaning of bodily sensations rather than the sensations themselves, which are mild, normal, or entirely absent.
• The care-seeking type schedules repeated visits, scans, and second opinions, while the care-avoidant type avoids doctors entirely out of fear of bad news.
• Body checking is constant: palpating lymph nodes, taking pulses, inspecting moles, and searching symptoms online for hours at a time.
• Reassurance from a normal test result relieves anxiety for days at most before doubt about accuracy, timing, or the wrong test returns.
• A personal or family history of serious illness, or a recent death from cancer, commonly triggers or sharply intensifies the preoccupation.
• Relationships strain as family members are enlisted for reassurance and then blamed for dismissiveness when the reassurance fails to hold.

Criteria snapshot

• Preoccupation with having or acquiring a serious illness is the central feature that defines the disorder and organizes the clinical picture.
• Somatic symptoms are absent or mild, and when another medical condition exists the preoccupation is clearly excessive or disproportionate to it.
• A high level of health anxiety is present, with the person easily alarmed about personal health status by minor cues or news reports.
• Excessive health-related behaviors such as repeated body checking are present, or there is maladaptive avoidance of doctors and hospitals.
• Illness preoccupation persists at least 6 months, though the specific feared condition may change, and is not better explained by another disorder.

Neurobiology

• Interoceptive prediction error is central, as the brain overweights prior expectations of illness relative to the actual incoming bodily signal.
• Insula and anterior cingulate hyperactivity in response to health-threat cues parallels the pattern found across the anxiety disorders generally.
• Amygdala reactivity with weak prefrontal regulation supports the rapid, sticky threat appraisals that characterize this disorder clinically.
• Serotonergic modulation is implicated, consistent with SSRI response rates comparable to those seen in obsessive-compulsive and panic disorder.
• Genetic overlap with anxiety disorders and obsessive-compulsive disorder is substantial, despite classification among somatic symptom disorders.
• Chronic autonomic arousal generates real palpitations, gastrointestinal upset, and muscle tension that supply fresh evidence for the feared disease.

Psychology

• Catastrophic misinterpretation of benign sensations, the core of the Warwick and Salkovskis cognitive model, is the central maintaining mechanism.
• Checking, reassurance-seeking, and internet searching function as safety behaviors that prevent disconfirmation and escalate steadily over time.
• Intolerance of uncertainty demands a guarantee of health that no test can deliver, which makes the pursuit of certainty inherently self-defeating.
• Selective attention toward the body lowers detection thresholds, so more sensations are noticed and each one then requires an explanation.
• Learning history matters: childhood illness, parental health anxiety, or a missed diagnosis in the family shapes the entire belief system.

Differential & comorbidity

• Somatic symptom disorder features prominent distressing somatic symptoms, whereas illness anxiety disorder places the fear itself at the center.
• Obsessive-compulsive disorder with contamination or illness obsessions spans multiple feared outcomes with ego-dystonic intrusions and rituals.
• Generalized anxiety worry ranges across many domains, and panic disorder fears immediate catastrophe in the moment rather than slow disease.
• Delusional disorder somatic type holds the belief with fixed conviction and no doubt, unlike the fluctuating conviction seen in illness anxiety.
• Major depression, generalized anxiety, and panic disorder are the most common comorbidities and should be identified and treated concurrently.

Pharmacologic treatment

• SSRIs are first line, including fluoxetine 20-60 mg/day, sertraline 50-200 mg/day, or escitalopram 10-20 mg/day for at least 12 weeks.
• Start at half the usual dose, because these patients monitor bodily sensations closely and readily interpret side effects as evidence of new illness.
• Higher obsessive-compulsive-range doses and longer trials are frequently required before an SSRI is declared a genuine treatment failure.
• Combining an SSRI with CBT outperforms either treatment alone in trials of severe, long-standing, or highly impairing presentations.
• Avoid benzodiazepines, which reinforce avoidance and blunt the anxiety tolerance that effective exposure-based work actually requires.

Psychotherapy

• CBT is the treatment of choice across 6-16 sessions, with large effect sizes maintained at 12-month follow-up in randomized controlled trials.
• Exposure and response prevention systematically eliminates body checking, reassurance-seeking, and internet searching while tolerating uncertainty.
• Behavioral experiments demonstrate how attention and checking themselves create sensations, replacing debate about whether disease is present.
• Mindfulness-based cognitive therapy reduces health anxiety by changing the relationship to intrusive illness thoughts rather than their content.
• Acceptance and commitment therapy redirects effort from certainty-seeking toward values-based living with uncertainty deliberately present.

Adjunct options

• Agree with the primary care clinician on scheduled visits and a testing policy so that reassurance stops being contingent on new symptom reports.
• Ban internet symptom searching outright and negotiate a specific, shrinking reassurance-seeking budget with partners and family members.
• Track severity with the Health Anxiety Inventory or the Whiteley Index at intake and again every 4-6 weeks to document real change.
• Internet-delivered CBT with therapist support shows efficacy comparable to face-to-face treatment and substantially improves access to care.
• Address the care-avoidant subtype directly, since delayed presentation and skipped cancer screening create genuine and preventable medical risk.

Clinical pearls

• The fear of disease, not the presence of symptoms, is what separates this from SSD.
• Reassurance is the safety behavior, so giving more of it makes the disorder worse.
• Treat it like OCD: an SSRI at high dose plus exposure and response prevention.